The Human Immunodeficiency Virus Type 1 Ribosomal Frameshifting Site Is an Invariant Sequence Determinant and an Important Target for Antiviral Therapy

Journal of Virology - United States
doi 10.1128/jvi.78.4.2082-2087.2004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

An Infectious Chimeric Human Immunodeficiency Virus Type 2 (HIV-2) Expressing the HIV-1 Principal Neutralizing Determinant.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1995English

Transcription Factor Binding Sites Downstream of the Human Immunodeficiency Virus Type 1 Transcription Start Site Are Important for Virus Infectivity.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1997English

The Principal Neutralization Determinant of Simian Immunodeficiency Virus Differs From That of Human Immunodeficiency Virus Type 1.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Multigene Antiviral Vectors Inhibit Diverse Human Immunodeficiency Virus Type 1 Clades.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1997English

Myosin-Actin Interaction Plays an Important Role in Human Immunodeficiency Virus Type 1 Release From Host Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

Target Cell Cyclophilin a Modulates Human Immunodeficiency Virus Type 1 Infectivity

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2004English

Low TRBP Levels Support an Innate Human Immunodeficiency Virus Type 1 Resistance in Astrocytes by Enhancing the PKR Antiviral Response

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2005English

Maintenance of the Gag/Gag-Pol Ratio Is Important for Human Immunodeficiency Virus Type 1 RNA Dimerization and Viral Infectivity

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

Antiviral Activity of Polyoxomol Ybdoeuropate PM-104 Against Human Immunodeficiency Virus Type 1.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy